Women with lupus and APS at risk of reduced fertility and pregnancy complication

June 11, 2015, European League Against Rheumatism

New recommendations by EULAR for women's health and pregnancy in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) were presented today at the European League Against Rheumatism Annual Congress (EULAR 2015). Developed by expert consensus, these evidence-based recommendations provide crucial guidance to support family planning, assisted reproduction, pregnancy and the menopause in these patients.

'APS and SLE disproportionately affect women, typically starting when they are at their most fertile, and leaving women at risk of reduced fertility and ,' said study investigator Dr. Laura Andreoli, Rheumatology and Clinical Immunology Unit, department of clinical and experimental sciences, University of Brescia, Italy. 'Women often develop these conditions before they have had a chance to have children or complete their family; physicians must ensure that optimal management includes best-practice measures to reduce these risks from the onset of disease and throughout pregnancy.'

Antiphospholipid syndrome is an autoimmune disorder that can cause the blood to clot, leaving patients at risk of deep vein or arterial thrombosis, and pregnancy complications including pre-eclampsia, foetal growth restriction and foetal loss.

SLE is a that can affect any organ system, but mainly involves the joints, kidneys and skin. SLE predominately affects women, occurring 10 times more often than in men and often starting when they are in their 20s and 30s.

The EULAR recommendations state that SLE or APS patients planning a pregnancy should be counselled and managed after assessment of risk that takes into consideration disease activity, serological profile, hypertension and use of drugs (with emphasis on hydroxychloroquine). Recommendations range from topics such as preservation of fertility to , and propose physicians to consider HPV immunisation in young women with stable or inactive disease.

The EULAR recommendations also include:

  • SLE and/or APS women can be candidates for contraceptive measures based on their disease activity and thrombotic risk (particularly presence of antiphospholipid antibodies)
  • Fertility preservation methods, including gonadotropin-releasing hormone (GnRH) analogues should be considered prior to the use of alkylating agents
  • Assisted reproduction techniques can be safely used in patients with stable or inactive disease provided that preventative measures are offered to limit the risk of flare and/or thrombosis
  • Disease activity, serological markers and renal function parameters are useful to monitor for obstetrical adverse outcomes and disease flares during pregnancy

Swedish population registry data investigating the impact of pregnancy and its complications (in the form of maternal-placental syndrome) on cardiovascular events in SLE were also presented today at EULAR.

The population-based retrospective study of 3,232 women with SLE (72 percent of whom had undergone childbirth), found that incidence of cardiovascular events was highest among who had never had children (3.4 per 1,000 person-years). These data led Soh et al. to conclude that pregnancy and its complications do not accelerate CVE to the same extent as SLE-related morbidity. The authors also hypothesised that severe SLE may reduce fertility and the chances of successful , further reinforcing the need for these EULAR recommendations.

Explore further: Pediatric discoid lupus carries significant progression risk

More information: Abstract Number: OP0086; OP0050

Related Stories

Pediatric discoid lupus carries significant progression risk

April 3, 2015
(HealthDay)—Pediatric discoid lupus erythematosus (DLE) carries a significant risk of progression to systemic lupus erythematosus (SLE), according to a review published in the April issue of the Journal of the American ...

Malaria drug combo could help prevent pregnancy complications in lupus patients

January 22, 2014
An anti-malaria drug combination might be useful in helping to prevent pregnancy complications in women with lupus and the related disorder antiphospholipid syndrome, Yale School of Medicine researchers have found in a new ...

Women with lupus have a higher risk for preeclampsia

October 30, 2012
New research reports that women with systemic lupus erythematosus (SLE) have a two-fold increase in risk of preeclampsia—a dangerous condition in which pregnant women develop high blood pressure (hypertension) and protein ...

Women with rheumatoid arthritis and lupus give birth to fewer children

February 16, 2012
New research shows that more than half of women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have fewer children than desired. While patient choice has some influence on the smaller family size, findings ...

Low vitamin D levels linked to lupus

April 30, 2015
Monash-led research has shown for the first time that low vitamin D levels are associated with higher disease activity in Australian lupus patients.

Study shows the HPV vaccine Gardasil doesn't increase disease activity in SLE patients

May 26, 2011
Results of a Chinese study showed that the HPV vaccine did not have significant effects on the number of disease flares or antibody measures in patients with inactive SLE receiving stable doses of medications after administration, ...

Recommended for you

Research shows diet has little influence on precursor to gout

October 11, 2018
Dietary factors have a far smaller influence on urate levels (a precursor to gout) than previously envisaged, new University of Otago research reveals.

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Antioxidant found to be effective in treating mice with osteoarthritis

September 14, 2018
A team of researchers in Belgium and the Netherlands has found that feeding a common antioxidant to test mice was effective in treating osteoarthritis. In their paper published in Science Translational Medicine, the group ...

Researchers find answers as to why some people are at risk of gout

September 12, 2018
University of Otago researchers have helped characterise a genetic variant that enables new understanding of why some people are at risk of gout, a painful and debilitating arthritic disease.

Emotions like anger and sadness may cause pain as well as being a result of it

September 10, 2018
While emotions such as anger or sadness are often thought of as being a result of stress or pain, findings recently published by Penn State researchers suggest that negative or mixed emotions could function as stressors themselves.

Dietary carbohydrates could lead to osteoarthritis, new study finds

August 9, 2018
Do your knees ache? According to new findings from the Oklahoma Medical Research Foundation, your diet could be a culprit.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.